-
UnitedHealth Group Statement Regarding Medicare Advantage
UnitedHealth Group Statement Regarding Medicare Advantage
Share
--(BUSINESS WIRE)--The Wall Street Journal continues to report misinformation on the Medicare Advantage (MA) program. The government regularly reviews all MA plans to ensure compliance and we consistently perform at the industry’s highest levels on those reviews. We are not aware of the “launch” of any “new” activity as reported by the Journal. We are aware, however, that the Journal has engaged in a year-long campaign to defend a legacy system that rewards volume over keeping patients healthy and addressing their underlying conditions. Any suggestion that our practices are fraudulent is outrageous and false.
Contacts
UnitedHealth Group
More News From UnitedHealth Group
New Independent Studies: Medicare Advantage Delivers Greater Value to the Federal Government and Beneficiaries than Traditional Medicare
--(BUSINESS WIRE)--UnitedHealth Group today announced the release of two new, independent commissioned actuarial studies. The findings, from the independent actuarial and research firm Milliman, using estimates of 2025 costs, summarize the value of Medicare Advantage (MA) both to the government and beneficiaries. Milliman found that: MA costs the federal government 9% less than traditional Medicare. MA out-of-pocket costs are 53% less than in traditional Medicare for a non-dual eligible aged-in...
Scott Gottlieb, M.D., Joins UnitedHealth Group Board of Directors
--(BUSINESS WIRE)--Dr. Scott Gottlieb, former U.S. Food and Drug Administration (FDA) commissioner, is joining UnitedHealth Group’s (NYSE: UNH) Board of Directors, effective immediately. Dr. Gottlieb, 53, served as FDA commissioner from 2017 to 2019, where he became known for promoting transparency, strengthening patient safety and widening consumer choice. He led initiatives to modernize regulations to help foster medical innovation, promote competition in the pharmaceutical market, confront t...
UnitedHealth Group Recommends Shareholders Reject "Mini-Tender" Offer by Tutanota
--(BUSINESS WIRE)--UnitedHealth Group (NYSE: UNH) today announced that it recently became aware of an unsolicited “mini-tender” offer by Tutanota LLC (Tutanota) to purchase up to 175,000 shares of UnitedHealth Group’s common stock, representing significantly less than 1% of UnitedHealth Group’s common stock outstanding. The offer price of $325.00 per share is conditioned on, among other things, the closing price per share of UnitedHealth Group’s common stock exceeding $325.00 per share on the l...
